CWA
ABBV icon

Clarity Wealth Advisors’s AbbVie ABBV Stock Holding History

Clarity Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.68M Buy
34,503
+685
+2% +$147K 1.53% 25
2026
Q1 		$7.36M Buy
33,818
+357
+1% +$79.2K 1.51% 26
2025
Q4 		$7.65M Buy
33,461
+679
+2% +$155K 1.56% 26
2025
Q3 		$7.59M Buy
32,782
+296
+0.9% +$60.3K 1.67% 25
2025
Q2 		$6.03M Buy
32,486
+529
+2% +$98.3K 1.49% 24
2025
Q1 		$6.7M Buy
31,957
+432
+1% +$84K 1.86% 20
2024
Q4 		$5.6M Buy
31,525
+1,119
+4% +$206K 1.53% 25
2024
Q3 		$6M Buy
30,406
+1,327
+5% +$248K 1.75% 18
2024
Q2 		$4.99M Sell
29,079
-1,087
-4% -$180K 1.61% 21
2024
Q1 		$5.49M Buy
30,166
+355
+1% +$61.2K 1.86% 18
2023
Q4 		$4.62M Buy
29,811
+784
+3% +$114K 1.75% 17
2023
Q3 		$4.33M Buy
29,027
+976
+3% +$143K 1.96% 17
2023
Q2 		$3.78M Buy
28,051
+802
+3% +$118K 1.7% 17
2023
Q1 		$4.34M Buy
27,249
+617
+2% +$94.3K 2.21% 15
2022
Q4 		$4.3M Sell
26,632
-257
-1% -$39.4K 2.48% 14
2022
Q3 		$3.61M Buy
26,889
+333
+1% +$47.8K 2.17% 15
2022
Q2 		$4.07M Buy
26,556
+662
+3% +$101K 2.33% 15
2022
Q1 		$4.2M Buy
25,894
+173
+0.7% +$25.1K 1.99% 17
2021
Q4 		$3.48M Buy
25,721
+974
+4% +$115K 1.62% 19
2021
Q3 		$2.67M Buy
24,747
+1,306
+6% +$149K 1.31% 23
2021
Q2 		$2.64M Buy
23,441
+1,569
+7% +$177K 1.37% 23
2021
Q1 		$2.37M Buy
21,872
+601
+3% +$64.3K 1.35% 24
2020
Q4 		$2.28M Buy
21,271
+641
+3% +$61.6K 1.38% 22
2020
Q3 		$1.81M Buy
20,630
+247
+1% +$23.3K 1.3% 22
2020
Q2 		$2M Buy
20,383
+535
+3% +$47.1K 1.58% 20
2020
Q1 		$1.51M Buy
19,848
+149
+0.8% +$12.7K 1.57% 21
2019
Q4 		$1.74M Buy
+19,699
New +$1.64M 1.47% 23

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Clarity Wealth Advisors's ABBV Position: Q2 2026 in Review

Clarity Wealth Advisors increased its AbbVie (ABBV) stake by 2% in Q2 2026, buying an estimated $147K and bringing the position to 34,503 shares worth $8.68M. The position accounts for 1.53% of the portfolio, ranked #25.

Clarity Wealth Advisors first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Clarity Wealth Advisors held 34,503 shares of AbbVie worth $8.68M as of Q2 2026.
  • Clarity Wealth Advisors bought 685 AbbVie shares in Q2 2026, an estimated $147K.
  • AbbVie made up 1.53% of Clarity Wealth Advisors's portfolio in Q2 2026, its #25 holding.
  • Clarity Wealth Advisors first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Clarity Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.